Logo image of LPSN

LIVEPERSON INC (LPSN) Stock Fundamental Analysis

NASDAQ:LPSN - Nasdaq - US5381461012 - Common Stock - Currency: USD

1.17  -0.05 (-4.1%)

After market: 1.15 -0.02 (-1.71%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LPSN. LPSN was compared to 283 industry peers in the Software industry. LPSN has a bad profitability rating. Also its financial health evaluation is rather negative. LPSN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LPSN had negative earnings in the past year.
LPSN had a negative operating cash flow in the past year.
In the past 5 years LPSN always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: LPSN reported negative operating cash flow in multiple years.
LPSN Yearly Net Income VS EBIT VS OCF VS FCFLPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of LPSN (-9.06%) is comparable to the rest of the industry.
The Return On Equity of LPSN (-136.52%) is worse than 81.52% of its industry peers.
Industry RankSector Rank
ROA -9.06%
ROE -136.52%
ROIC N/A
ROA(3y)-14.43%
ROA(5y)-14.54%
ROE(3y)-191.95%
ROE(5y)-136.93%
ROIC(3y)N/A
ROIC(5y)N/A
LPSN Yearly ROA, ROE, ROICLPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300

1.3 Margins

LPSN has a Gross Margin of 66.52%. This is comparable to the rest of the industry: LPSN outperforms 48.19% of its industry peers.
In the last couple of years the Gross Margin of LPSN has declined.
LPSN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.18%
GM growth 5Y-2.99%
LPSN Yearly Profit, Operating, Gross MarginsLPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

LPSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LPSN has more shares outstanding
The number of shares outstanding for LPSN has been increased compared to 5 years ago.
LPSN has a worse debt/assets ratio than last year.
LPSN Yearly Shares OutstandingLPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
LPSN Yearly Total Debt VS Total AssetsLPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -1.53, we must say that LPSN is in the distress zone and has some risk of bankruptcy.
LPSN's Altman-Z score of -1.53 is on the low side compared to the rest of the industry. LPSN is outperformed by 77.17% of its industry peers.
LPSN has a Debt/Equity ratio of 10.24. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 10.24, LPSN is doing worse than 88.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 10.24
Debt/FCF N/A
Altman-Z -1.53
ROIC/WACCN/A
WACC2.34%
LPSN Yearly LT Debt VS Equity VS FCFLPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

LPSN has a Current Ratio of 1.27. This is a normal value and indicates that LPSN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.27, LPSN is not doing good in the industry: 62.32% of the companies in the same industry are doing better.
A Quick Ratio of 1.27 indicates that LPSN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.27, LPSN is doing worse than 61.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
LPSN Yearly Current Assets VS Current LiabilitesLPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.28% over the past year.
The Revenue for LPSN has decreased by -21.97% in the past year. This is quite bad
The Revenue has been growing by 9.98% on average over the past years. This is quite good.
EPS 1Y (TTM)43.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.94%
Revenue 1Y (TTM)-21.97%
Revenue growth 3Y3.12%
Revenue growth 5Y9.98%
Sales Q2Q%-26.73%

3.2 Future

LPSN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.74% yearly.
The Revenue is expected to decrease by -13.31% on average over the next years. This is quite bad
EPS Next Y59.64%
EPS Next 2Y13.65%
EPS Next 3Y-3.74%
EPS Next 5YN/A
Revenue Next Year-23.25%
Revenue Next 2Y-19.97%
Revenue Next 3Y-13.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LPSN Yearly Revenue VS EstimatesLPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
LPSN Yearly EPS VS EstimatesLPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LPSN. In the last year negative earnings were reported.
Also next year LPSN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LPSN Price Earnings VS Forward Price EarningsLPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LPSN Per share dataLPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

LPSN's earnings are expected to decrease with -3.74% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.65%
EPS Next 3Y-3.74%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LPSN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIVEPERSON INC

NASDAQ:LPSN (2/21/2025, 8:00:00 PM)

After market: 1.15 -0.02 (-1.71%)

1.17

-0.05 (-4.1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners24.58%
Inst Owner Change-98.17%
Ins Owners6.36%
Ins Owner Change21.31%
Market Cap106.29M
Analysts49.09
Price Target0.98 (-16.24%)
Short Float %12.69%
Short Ratio2.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)145.3%
Min EPS beat(2)-41.32%
Max EPS beat(2)331.92%
EPS beat(4)1
Avg EPS beat(4)53.07%
Min EPS beat(4)-52.62%
Max EPS beat(4)331.92%
EPS beat(8)3
Avg EPS beat(8)0.49%
EPS beat(12)6
Avg EPS beat(12)17.18%
EPS beat(16)10
Avg EPS beat(16)101.92%
Revenue beat(2)2
Avg Revenue beat(2)1.78%
Min Revenue beat(2)1.22%
Max Revenue beat(2)2.33%
Revenue beat(4)3
Avg Revenue beat(4)1.62%
Min Revenue beat(4)-0.57%
Max Revenue beat(4)3.47%
Revenue beat(8)4
Avg Revenue beat(8)-0.18%
Revenue beat(12)6
Avg Revenue beat(12)-0.23%
Revenue beat(16)9
Avg Revenue beat(16)0.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-43.23%
EPS NQ rev (3m)-43.23%
EPS NY rev (1m)8.64%
EPS NY rev (3m)-52.27%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 2.32
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.76
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS3.68
BVpS0.51
TBVpS-3.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.06%
ROE -136.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.52%
FCFM N/A
ROA(3y)-14.43%
ROA(5y)-14.54%
ROE(3y)-191.95%
ROE(5y)-136.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.18%
GM growth 5Y-2.99%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 10.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 63.14%
Cap/Sales 9.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z -1.53
F-Score4
WACC2.34%
ROIC/WACCN/A
Cap/Depr(3y)100%
Cap/Depr(5y)143.23%
Cap/Sales(3y)9.45%
Cap/Sales(5y)11.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.94%
EPS Next Y59.64%
EPS Next 2Y13.65%
EPS Next 3Y-3.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-21.97%
Revenue growth 3Y3.12%
Revenue growth 5Y9.98%
Sales Q2Q%-26.73%
Revenue Next Year-23.25%
Revenue Next 2Y-19.97%
Revenue Next 3Y-13.31%
Revenue Next 5YN/A
EBIT growth 1Y12.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year432.27%
EBIT Next 3Y70.67%
EBIT Next 5YN/A
FCF growth 1Y76.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.31%
OCF growth 3YN/A
OCF growth 5YN/A